Luther12
Elder Lister
A pill has cut the risk of hospitalization or death from Covid-19 by half in a study, Merck and Ridgeback Biotherapeutics said Friday.
It would become the first oral medicine that fights viral infection for Covid-19 if approved by the US Food and Drug Administration for emergency use authorization.
edition.cnn.com
An experimental drug for severe Covid cuts the risk of hospitalisation or death by about half, interim clinical trial results suggest.
The tablet - molnupiravir - was given twice a day to patients recently diagnosed with the disease.
US drug-maker Merck said its results were so positive that outside monitors had asked to stop the trial early.
It said it would apply for emergency use authorisation for the drug in the US in the next two weeks.
It would become the first oral medicine that fights viral infection for Covid-19 if approved by the US Food and Drug Administration for emergency use authorization.
US surpasses 700,000 Covid-19 deaths | CNN
The US surpassed 700,000 deaths from Covid-19 on Friday, 108 days after the country reached 600,000 deaths from the virus, according to data from Johns Hopkins University.
An experimental drug for severe Covid cuts the risk of hospitalisation or death by about half, interim clinical trial results suggest.
The tablet - molnupiravir - was given twice a day to patients recently diagnosed with the disease.
US drug-maker Merck said its results were so positive that outside monitors had asked to stop the trial early.
It said it would apply for emergency use authorisation for the drug in the US in the next two weeks.
Covid antiviral pill can halve risk of hospitalisation
Promising results mean a clinical trial has ended early and emergency authorisation is being sought.
www.bbc.com
